Correlation Between Cassava Sciences and Iovance Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Cassava Sciences and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cassava Sciences and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cassava Sciences and Iovance Biotherapeutics, you can compare the effects of market volatilities on Cassava Sciences and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cassava Sciences with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cassava Sciences and Iovance Biotherapeutics.
Diversification Opportunities for Cassava Sciences and Iovance Biotherapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cassava and Iovance is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Cassava Sciences and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Cassava Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cassava Sciences are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Cassava Sciences i.e., Cassava Sciences and Iovance Biotherapeutics go up and down completely randomly.
Pair Corralation between Cassava Sciences and Iovance Biotherapeutics
Given the investment horizon of 90 days Cassava Sciences is expected to under-perform the Iovance Biotherapeutics. In addition to that, Cassava Sciences is 2.78 times more volatile than Iovance Biotherapeutics. It trades about -0.12 of its total potential returns per unit of risk. Iovance Biotherapeutics is currently generating about -0.03 per unit of volatility. If you would invest 1,085 in Iovance Biotherapeutics on September 1, 2024 and sell it today you would lose (153.00) from holding Iovance Biotherapeutics or give up 14.1% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cassava Sciences vs. Iovance Biotherapeutics
Performance |
Timeline |
Cassava Sciences |
Iovance Biotherapeutics |
Cassava Sciences and Iovance Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cassava Sciences and Iovance Biotherapeutics
The main advantage of trading using opposite Cassava Sciences and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cassava Sciences position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.Cassava Sciences vs. Annovis Bio | Cassava Sciences vs. Axsome Therapeutics | Cassava Sciences vs. Reviva Pharmaceuticals Holdings | Cassava Sciences vs. Seres Therapeutics |
Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |